Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Top Research Reports for T-Mobile, Deere & PayPal
07:05pm, Friday, 29'th Apr 2022 Zacks Investment Research
Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Deere & Company (DE), and PayPal Holdings, Inc. (PYPL).
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
01:45pm, Friday, 29'th Apr 2022 Zacks Investment Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
IART vs. EW: Which Stock Is the Better Value Option?
12:47pm, Thursday, 28'th Apr 2022
IART vs. EW: Which Stock Is the Better Value Option?
5 Quality Stocks With High GF Scores and Momentum
06:18pm, Wednesday, 27'th Apr 2022
In light of U.S. markets gyrating up and down during the final week of April, five high-quality stocks with high GF Scores and momentum ranks include Apple Inc. ( AAPL , Financial), Alphabet Inc. ( GO
Edwards Lifesciences Clocks 10% Top-Line Growth In Q1; Forecasts Lower Than Expected Q2 Sales
12:38pm, Wednesday, 27'th Apr 2022 Benzinga
Edwards Lifesciences Corp (NYSE: EW) posted a Q1 adjusted EPS of $0.60, compared to $0.54 posted a year ago and beating the consensus of $0.57.
Sales increased 10% to $1.34 billion (underlying 13%),
Edwards Lifesciences (EW) Q1 Earnings Top Estimates, Margins Up
10:49am, Wednesday, 27'th Apr 2022
Increased adoption of the PASCAL platform along with continued strength in the HemoSphere monitoring platform drove Edwards Lifesciences' (EW) Q1 revenues.
Edwards Lifesciences Clocks 10% Top-Line Growth In Q1; Forecasts Lower Than Expected Q2 Sales
08:43am, Wednesday, 27'th Apr 2022
Edwards Lifesciences Corp (NYSE: EW) posted a Q1 adjusted EPS of $0.60, compared to $0.54 posted a year ago and beating the consensus of $0.57. Sales increased 10% to $1.34 billion (underlying 13%),
Edwards Lifesciences (EW) Q1 2022 Earnings Call Transcript
05:30am, Wednesday, 27'th Apr 2022 The Motley Fool
EW earnings call for the period ending March 31, 2022.
Edwards Lifesciences (EW) Beats Q1 Earnings and Revenue Estimates
09:35pm, Tuesday, 26'th Apr 2022 Zacks Investment Research
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 3.45% and 2.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Edwards Lifesciences Corporation (EW) CEO Mike Mussallem on Q1 2022 Results - Earnings Call Transcript
08:09pm, Tuesday, 26'th Apr 2022
Edwards Lifesciences Corporation (NYSE:EW ) Q1 2022 Earnings Conference Call April 26, 2022 5:00 PM ET Company Participants Mark Wilterding - Vice President, Investor Relations & Treasurer Mike Mussal
Edwards Lifesciences (EW) Beats Q1 Earnings and Revenue Estimates
07:34pm, Tuesday, 26'th Apr 2022
Edwards Lifesciences (EW) delivered earnings and revenue surprises of 3.45% and 2.44%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Humana (HUM) Gears Up For Q1 Earnings: What's in the Cards?
02:22pm, Thursday, 21'st Apr 2022 Zacks Investment Research
Humana's (HUM) first-quarter earnings are likely to reflect the impacts of elevated costs related to investments in technology advancements, partly offset by higher premiums in the Retail segment and
Edwards Lifesciences (EW) to Post Q1 Earnings: What's in Store?
12:47pm, Wednesday, 20'th Apr 2022 Zacks Investment Research
Improvement in TAVR and TMTT businesses is expected to have contributed to Edwards Lifesciences' (EW) first-quarter performance.
Edwards Lifesciences (EW) to Post Q1 Earnings: What's in Store?
10:32am, Wednesday, 20'th Apr 2022
Improvement in TAVR and TMTT businesses is expected to have contributed to Edwards Lifesciences' (EW) first-quarter performance.
Edwards Lifesciences (EW) Earnings Expected to Grow: Should You Buy?
07:01pm, Tuesday, 19'th Apr 2022 Zacks Investment Research
Edwards Lifesciences (EW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
